JP2023116739A5 - - Google Patents

Download PDF

Info

Publication number
JP2023116739A5
JP2023116739A5 JP2023100171A JP2023100171A JP2023116739A5 JP 2023116739 A5 JP2023116739 A5 JP 2023116739A5 JP 2023100171 A JP2023100171 A JP 2023100171A JP 2023100171 A JP2023100171 A JP 2023100171A JP 2023116739 A5 JP2023116739 A5 JP 2023116739A5
Authority
JP
Japan
Prior art keywords
peptide
hinge region
peptide according
seq
helical domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023100171A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023116739A (ja
Filing date
Publication date
Priority claimed from JP2019539809A external-priority patent/JP7353973B2/ja
Application filed filed Critical
Publication of JP2023116739A publication Critical patent/JP2023116739A/ja
Publication of JP2023116739A5 publication Critical patent/JP2023116739A5/ja
Pending legal-status Critical Current

Links

JP2023100171A 2017-01-19 2023-06-19 Apoc-ii模倣ペプチド Pending JP2023116739A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201762448358P 2017-01-19 2017-01-19
US62/448,358 2017-01-19
US201762476535P 2017-03-24 2017-03-24
US201762476531P 2017-03-24 2017-03-24
US62/476,535 2017-03-24
US62/476,531 2017-03-24
JP2019539809A JP7353973B2 (ja) 2017-01-19 2018-01-19 Apoc-ii模倣ペプチド
PCT/US2018/014532 WO2018136803A1 (en) 2017-01-19 2018-01-19 Apoc-ii mimetic peptides

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019539809A Division JP7353973B2 (ja) 2017-01-19 2018-01-19 Apoc-ii模倣ペプチド

Publications (2)

Publication Number Publication Date
JP2023116739A JP2023116739A (ja) 2023-08-22
JP2023116739A5 true JP2023116739A5 (cg-RX-API-DMAC7.html) 2023-12-05

Family

ID=62908746

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019539809A Active JP7353973B2 (ja) 2017-01-19 2018-01-19 Apoc-ii模倣ペプチド
JP2023100171A Pending JP2023116739A (ja) 2017-01-19 2023-06-19 Apoc-ii模倣ペプチド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019539809A Active JP7353973B2 (ja) 2017-01-19 2018-01-19 Apoc-ii模倣ペプチド

Country Status (14)

Country Link
US (2) US11136372B2 (cg-RX-API-DMAC7.html)
EP (1) EP3571216B1 (cg-RX-API-DMAC7.html)
JP (2) JP7353973B2 (cg-RX-API-DMAC7.html)
KR (1) KR102700862B1 (cg-RX-API-DMAC7.html)
CN (1) CN110831957B (cg-RX-API-DMAC7.html)
AU (1) AU2018210404B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019014707A2 (cg-RX-API-DMAC7.html)
CA (1) CA3050106A1 (cg-RX-API-DMAC7.html)
IL (2) IL268093B2 (cg-RX-API-DMAC7.html)
MX (1) MX2019008529A (cg-RX-API-DMAC7.html)
NZ (1) NZ755599A (cg-RX-API-DMAC7.html)
SG (2) SG11201906422VA (cg-RX-API-DMAC7.html)
TW (2) TW202130652A (cg-RX-API-DMAC7.html)
WO (1) WO2018136803A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018210404B2 (en) 2017-01-19 2022-01-27 Novo Nordisk A/S ApoC-II mimetic peptides
US20240309065A1 (en) * 2021-06-23 2024-09-19 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Short apoc-ii mimetic peptides and methods of use
CN119233984A (zh) * 2022-05-05 2024-12-31 美国政府(由卫生和人类服务部的部长所代表) 短载脂蛋白e模拟肽及其使用方法
US20240043499A1 (en) * 2022-08-07 2024-02-08 Protean Bio, Inc. Peptides for beta-cell survival and insulin production

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
EP0206448B1 (en) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US6156727A (en) * 1996-09-05 2000-12-05 Uab Research Foundation Anti-atherosclerotic peptides and a transgenic mouse model of antherosclerosis
NZ532217A (en) 2001-09-28 2006-12-22 Esperion Therapeutics Inc Use of an alpha helical apolipoprotein or HDL associating protein adapted to be administered locally to prevent or reduce stenosis or restenosis or to stabilize a plaque
US7220576B2 (en) * 2002-01-07 2007-05-22 Lifesensors, Inc. Methods and compositions for protein expression and purification
CA2512879A1 (en) * 2003-01-17 2004-08-12 Soumya P. Sahoo N-cyclohexylaminocarbonyl benzenesulfonamide derivatives
EP1706131A4 (en) * 2003-12-15 2009-08-12 Univ California THE CELLULAR CHOLESTEROL EFFLUX STIMULATING HELICULAR SYNTHETIC PEPTIDES
AU2005214225B2 (en) * 2004-02-19 2010-05-20 Banyu Pharmaceutical Co., Ltd. Novel sulfone amide derivative
JP5048486B2 (ja) * 2004-07-16 2012-10-17 トラスティーズ オブ タフツ カレッジ アポリポタンパク質a1の模倣物とその使用
AU2006263332B2 (en) * 2005-06-29 2012-02-23 Hadasit Medical Research Services & Development Ltd. Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes
US20080138284A1 (en) * 2006-09-26 2008-06-12 Lipid Sciences, Inc. Novel Peptides That Promote Lipid Efflux
WO2009097584A1 (en) * 2008-01-30 2009-08-06 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
WO2009129263A1 (en) * 2008-04-15 2009-10-22 The Government Of The Usa As Represented By The Secretary Of The Department Of Health & Human Serv. Peptides promoting lipid efflux via abca1 and activating a lipoprotein lipase
CN102753576A (zh) * 2009-09-30 2012-10-24 首尔大学教产学协力团 载脂蛋白a-1模拟肽以及包含其的用于治疗高血脂及高血脂相关疾病的治疗剂
US10087234B2 (en) 2012-11-06 2018-10-02 Les Hopitaux Universitaires De Geneve Mimetic peptides
AU2018210404B2 (en) 2017-01-19 2022-01-27 Novo Nordisk A/S ApoC-II mimetic peptides
EA201991491A1 (ru) 2017-03-24 2019-12-30 Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сервисис Миметические пептиды apoc-ii

Similar Documents

Publication Publication Date Title
US6610820B1 (en) Cell-permeable peptide inhibitors of the JNK signal transduction pathway
JP2021506814A5 (cg-RX-API-DMAC7.html)
US8569235B2 (en) Treatment of kidney disorders with VIP fragments
CA2945838C (en) Modified relaxin b chain peptides
IL192046A (en) Intact and peptide intestinal fragments and methods of use
JP2011518179A5 (cg-RX-API-DMAC7.html)
CN101490081A (zh) 用于抑制神经元nmda受体(nmdar)与nmdar相互作用蛋白的相互作用的融合肽
JP2019533722A5 (cg-RX-API-DMAC7.html)
JPWO2019156137A5 (cg-RX-API-DMAC7.html)
JP2015504052A5 (cg-RX-API-DMAC7.html)
JP2010536714A5 (cg-RX-API-DMAC7.html)
JP2024528407A5 (cg-RX-API-DMAC7.html)
AU2016277449B2 (en) Protease-resistant lipidated GLP-1 analogs
JP2025172140A5 (cg-RX-API-DMAC7.html)
AU764218B2 (en) Threonine-containing protegrins
JP2020511425A5 (cg-RX-API-DMAC7.html)
JP2025519127A5 (cg-RX-API-DMAC7.html)
JPWO2023282281A5 (cg-RX-API-DMAC7.html)
JPWO2016063969A1 (ja) ヘマグルチニン結合ペプチド
NZ755599A (en) Apoc-ii mimetic peptides
EP2089419A2 (en) Inhibition of beta-amyloid aggregation
JP2023509187A5 (cg-RX-API-DMAC7.html)
EP1137659A1 (en) Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
JP2015506960A5 (cg-RX-API-DMAC7.html)
JP2006523181A5 (cg-RX-API-DMAC7.html)